Entity family
Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.
This treatment is selected. Its supporting articles are shown below.
…d in 2017, evaluated immune checkpoint inhibitors (ICIs) versus chemotherapy in the first-line treatment of non-small cell lung cancer (NSCL…
…ers in resectable NSCLC receiving neoadjuvant camrelizumab plus chemotherapy.Trial registration number NCT06241807.…
…coma, and staging imaging suggested liver metastases, prompting chemotherapy initiation. One month later, she developed urinary retention, o…
…rotein 1/programmed cell death ligand 1 (PD-L1) inhibitors with chemotherapy and reported sex-specific OS and/or PFS outcomes. HRs were pool…
…this is the first clinical study in this setting to investigate chemotherapy combined with three immunotherapy agents, aiming to overcome fa…
…ss and safety of weight-based pembrolizumab in combination with chemotherapy as neoadjuvant treatment for locally advanced or early-stage TN…
…ion and type, administered therapy, and patient characteristics.Chemotherapy increases this risk by 6,5 times, having a significant impact o…
…esponse, mogamulizumab was consequently combined off-label with DA-EPOCH chemotherapy. Clinical outcomes were assessed using PET/CT imaging, symptom …
…022 and July 2025 was conducted to identify incidents involving chemotherapy spills. Subsequently, a 1 month survey was carried out among nu…
….58; p <0.001) and CheckMate 901 trial assessed Nivolumab-CT vs chemotherapy (HR 0.78; 95% CI 0.63-0.96; p=0.02). Chemotherapy (gemcitabine …
…elin, and CEA emerged as the most frequently targeted antigens. Autologous therapy administered via peripheral intravenous infusion represented th…
…carcinoma) had received five prior lines of treatment including chemotherapy, anti-epidermal growth factor receptor, anti-PD-L1 and investig…